Regulation of transcription of the tax transgene and tax-induced genes in tumor cell lines of the LTR-tax transgenic mouse. NLM AIDSLINE Important note: Information in this article was accurate in 1994. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


Regulation of transcription of the tax transgene and tax-induced genes in tumor cell lines of the LTR-tax transgenic mouse.

Diss Abstr Int [B]; 53(9):4501 1993. Unique Identifier : AIDSLINE ICDB/94690786
Fontes JD; Univ. of California, Davis


Abstract: The LTR-tax transgenic mouse develops peripheral neurofibromas as its primary pathologic feature. An in vitro cell line (Px-1 cells) derived from one of these tumors provides an excellent model for the study of tax-driven neoplasia. Using these cells, the role of tax in the trans-activation of cellular genes and the transgene itself was studied. It was determined that tax and activating transcription factor-1 (ATF-1) are both present in complexes that form between extracts of the Px-1 cell line and viral long terminal repeat (LTR) DNA sequences. Treatment of Px-1 cells with protein kinase A and protein kinase C activating agents led to an intensification of these protein-DNA complexes. Using recombinant proteins, it was also demonstrated that tax increases the binding of ATF-1 to sequences in the LTR, a result that was also obtained by treating ATF-1 with protein kinase A in vitro. The expression of several growth factors was also examined in Px-1 cells. Potential tax-responsive DNA elements from promoter regions of several factors were examined for activity in Px-1 cells using reporter constructs. Only one sequence from granulocyte-macrophage colony stimulating factor (GMCSF) was found to increase expression over basal levels. Treatment of Px-1 cells with 8-bromoadenosine 3':5'-cyclic monophosphate (8Br-cAMP) led to an initial increase in messenger RNA for GMCSF, followed by a sharp decline. It was demonstrated that tax is phosphorylated in response to 8Br-cAMP treatment of the Px-1 cells, and that the previously identified tax-responsive GMCSF enchancer was responsive to 8Br-cAMP, even though there is no cAMP responsive enchancer present. (Full text available from University Microfilms International, Ann Arbor, MI, as Order No. AAD93-02595.)
Keywords: Animal Cyclic AMP-Dependent Protein Kinases/METABOLISM Enzyme Activation Gene Products, tax/*GENETICS Granulocyte-Macrophage Colony-Stimulating Factor/GENETICS/ METABOLISM Mice Mice, Transgenic Protein Kinase C/METABOLISM Repetitive Sequences, Nucleic Acid RNA, Messenger/METABOLISM *Transcription, Genetic Tumor Cells, Cultured 8-Bromo Cyclic Adenosine Monophosphate/PHARMACOLOGY THESIS

KWDanimalcyclicamp-dependentproteinkinases/metabolismenzymeactivationgeneproducts,tax/KWDgeneticsgranulocyte-macrophagecolony-stimulatingfactor/genetics/metabolismmicemice,transgenicproteinkinasec/metabolismrepetitivesequences,nucleicacidrna,messenger/metabolismKWDtranscription,genetictumorcells,cultured8-bromocyclicadenosinemonophosphate/pharmacologythesis
940930
M9491071


Copyright © 1994 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1994. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1994. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .